Wellington Shields & Co. LLC decreased its stake in Express Scripts Holding Company (NASDAQ:ESRX) by 1.0% during the first quarter, Holdings Channel reports. The fund owned 122,076 shares of the company’s stock after selling 1,190 shares during the period. Express Scripts Holding Company makes up approximately 2.4% of Wellington Shields & Co. LLC’s investment portfolio, making the stock its 5th largest position. Wellington Shields & Co. LLC’s holdings in Express Scripts Holding Company were worth $8,046,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. United Services Automobile Association increased its position in Express Scripts Holding Company by 8.9% in the third quarter. United Services Automobile Association now owns 925,197 shares of the company’s stock valued at $65,254,000 after buying an additional 75,567 shares in the last quarter. Allen Investment Management LLC increased its position in Express Scripts Holding Company by 11.0% in the third quarter. Allen Investment Management LLC now owns 1,040,820 shares of the company’s stock valued at $73,409,000 after buying an additional 103,015 shares in the last quarter. AMP Capital Investors Ltd increased its position in Express Scripts Holding Company by 5.3% in the third quarter. AMP Capital Investors Ltd now owns 413,996 shares of the company’s stock valued at $28,916,000 after buying an additional 20,913 shares in the last quarter. Hartford Investment Management Co. increased its position in Express Scripts Holding Company by 2.6% in the third quarter. Hartford Investment Management Co. now owns 168,543 shares of the company’s stock valued at $11,887,000 after buying an additional 4,305 shares in the last quarter. Finally, Global Endowment Management LP purchased a new position in Express Scripts Holding Company during the third quarter valued at approximately $3,668,000. 85.36% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)

Express Scripts Holding Company (NASDAQ:ESRX) opened at 60.40 on Friday. The stock has a market capitalization of $35.85 billion, a PE ratio of 10.95 and a beta of 0.92. The stock’s 50 day moving average price is $61.86 and its 200-day moving average price is $68.00. Express Scripts Holding Company has a 12-month low of $57.80 and a 12-month high of $80.02.

Express Scripts Holding Company (NASDAQ:ESRX) last issued its quarterly earnings results on Monday, April 24th. The company reported $1.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.32 by $0.01. The firm had revenue of $24.65 billion during the quarter, compared to analyst estimates of $24.95 billion. Express Scripts Holding Company had a return on equity of 24.99% and a net margin of 2.70%. The firm’s quarterly revenue was down .6% on a year-over-year basis. During the same period last year, the company posted $1.22 EPS. Analysts expect that Express Scripts Holding Company will post $6.97 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Express Scripts Holding Company (ESRX) Shares Sold by Wellington Shields & Co. LLC” was posted by Watch List News and is the property of of Watch List News. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.watchlistnews.com/express-scripts-holding-company-esrx-shares-sold-by-wellington-shields-co-llc/1327179.html.

Several research analysts recently commented on ESRX shares. Vetr raised Express Scripts Holding Company from a “buy” rating to a “strong-buy” rating and set a $79.36 price objective for the company in a research note on Monday, March 6th. Robert W. Baird reduced their price objective on Express Scripts Holding Company from $73.00 to $53.00 and set a “neutral” rating for the company in a research note on Tuesday, April 25th. Morgan Stanley reduced their price objective on Express Scripts Holding Company from $71.00 to $52.00 and set an “underweight” rating for the company in a research note on Wednesday, April 26th. Wells Fargo & Co downgraded Express Scripts Holding Company from a “market perform” rating to an “underperform” rating in a research note on Wednesday, March 15th. Finally, SunTrust Banks, Inc. reissued a “buy” rating on shares of Express Scripts Holding Company in a research note on Tuesday, April 25th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $71.95.

In other Express Scripts Holding Company news, VP Phyllis S. Anderson sold 1,100 shares of the stock in a transaction on Friday, May 19th. The stock was sold at an average price of $60.08, for a total transaction of $66,088.00. Following the completion of the transaction, the vice president now directly owns 11,108 shares of the company’s stock, valued at approximately $667,368.64. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.54% of the company’s stock.

Express Scripts Holding Company Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.